Morbidity and Mortality - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

Morbidity and Mortality

Description:

Morbidity and Mortality. By. James Yost, MD, MS, MBA. PGY 2. Emory Family Medicine. psp.about.com – PowerPoint PPT presentation

Number of Views:202
Avg rating:3.0/5.0
Slides: 23
Provided by: fpmEmoryE
Learn more at: https://med.emory.edu
Category:

less

Transcript and Presenter's Notes

Title: Morbidity and Mortality


1
Morbidity and Mortality
  • By
  • James Yost, MD, MS, MBA
  • PGY 2
  • Emory Family Medicine

psp.about.com
2
Gram-Negative Bacillary Meningitis
  • Background
  • 1805
  • Meningitis was originally recognized and was
    virtually 100 percent fatal.
  • 1892
  • Gram-negative meningitis was first recognized
  • 1930s and 40s
  • Cases were described resulting from abortion,
    genitourinary manipulation, and spinal anesthesia
  • 1950s and 60s
  • Recognized as an occasional complication of
    injuries and neurosurgical procedures

3
Gram-Negative Bacillary Meningitis
  • Background Continued
  • Two age groups are affected
  • Neonates/infants
  • Adults
  • community-acquired meningitis
  • nosocomial meningitis

4
Gram-Negative Bacillary Meningitis
  • Epidemiology
  • Frequency
  • Gram-negative bacilli account for 1.5 4.3 of
    all cases of meningitis
  • E. coli and Klebsiella account for more than
    50-70 of cases of gram-negative bacillary
    meningitis
  • There was an inverse relationship with age with
    E. coli
  • 74 E. coli in neonates
  • 10 E. coli and 40 Klebsiella in adults

5
Gram-Negative Bacillary Meningitis
  • Epidemiology
  • Frequency
  • Neonatal and infant meningitis
  • Gram-negative bacilli are the fifth most common
    cause accounting for 3.6 of all cases
  • 40.3 of all Gram-negative bacilli cases occur in
    this age group
  • 53 of those were caused by E. coli
  • Community-acquired gram-negative meningitis
  • accounting for only 9 of 253 episodes (3.6) in a
    report from the United States

6
Gram-Negative Bacillary Meningitis
  • Epidemiology
  • Frequency Continued
  • Nosocomial acquired gram-negative meningitis
  • 33-69 of bacterial meningitis are believed to
    nosocomial
  • 36 to 50 of cases occurred after neurosurgical
    procedures
  • Associated bacteremia
  • Neonates and infants were 55
  • Community-acquired gram-negative meningitis were
    58
  • Nosocomial were 43

7
Gram-Negative Bacillary Meningitis
  • Epidemiology
  • Mortality/Morbidity
  • The mortality rate of untreated disease
    approaches 100 percent.
  • The mortality in adults and children with
    gram-negative meningitis has ranged from 40 to
    80
  • E. coli meningitis has a mortality rate from 50
    to 90, in patients in a coma or with bacteremia
  • Transient or permanent neurologic morbidity
    occurred in 21 to 28 of survivors

8
Gram-Negative Bacillary Meningitis
  • Epidemiology
  • Mortality/Morbidity Continued
  • Three baseline clinical features were
    independently associated with an adverse outcome
    (defined as in-hospital death or neurologic
    deficit at discharge)
  • hypotension, altered mental status, and seizures
  • 9 adverse outcome had no clinical risk factors
  • 33 adverse outcome had intermediate risk (one
    clinical factor)
  • 57 adverse outcome had high risk (two or three
    clinical factors)

9
Gram-Negative Bacillary Meningitis
  • Epidemiology
  • Risk Factors
  • In a report of 197 cases of nosocomial
    meningitis, the major risk factors were
  • neurosurgery or head trauma within the past month
  • a neurosurgical device
  • a CSF leak.
  • These accounted for 75 percent of cases
  • Vaginal birth and the hands of health care
    workers
  • Immunocompromised states for community-acquired

10
Gram-Negative Bacillary Meningitis
  • Pathophysiology
  • The CSF is normally deficient in immunoglobulins
  • The development of bacterial meningitis
    progresses through four interconnected phases
  • Bacterial invasion of the host with subsequent
    infection of the CNS
  • Bacterial multiplication and induction of
    inflammation in the subarachnoid and ventricular
    space
  • Progression of inflammation with associated
    pathophysiologic alterations
  • Development of neuronal damage

11
E. coli Meningitis
  • Pathophysiology Continued
  • E. coli have two mechanisms that aid in the
    pathogenesis of meningitis
  • K1 capsular polysaccharide
  • bacterial capsule
  • Similar to those of S. pneumoniae, N.
    meningitidis, and Haemophilus influenzae
  • Can assist the organism in evading host defenses
  • S fimbriae
  • Facilitates CSF entry particularly at the choroid
    plexus

12
E. Coli Meningitis
  • Clinical History
  • head trauma
  • neurosurgery
  • debilitated patients
  • elderly people
  • alcoholics
  • diabetics
  • cancer
  • immunosuppressive state

13
E. Coli Meningitis
  • Clinical History Continued
  • Most cases of postoperative gram-negative
    meningitis occur 10 or more days after surgery
  • Range of 1-20 days
  • The time interval is similar in infants, with a
    mean of 5.5 days following surgery
  • Range 1 to 15 days

14
E. Coli Meningitis
  • Causes
  • Neonatal E. coli meningitis
  • acquired during or soon after delivery
  • vaginal flora of the mother
  • the hands of hospital personnel
  • Nosocomial E. coli meningitis
  • neurosurgery
  • head trauma within the past month
  • a neurosurgical device
  • CSF leak
  • temporary epidural catheters
  • tunneled intraspinal catheter systems

15
E. Coli Meningitis
  • Causes Continued
  • Community-acquired meningitis
  • Any Immunosuppressed state
  • Alcohol-induced cirrhosis
  • Diabetes
  • Malignancy
  • Splenectomy
  • glucocorticoid therapy
  • Instrumentation of the urinary tract

16
E. Coli Meningitis
  • Treatment for the Adult
  • Vancomycin to cefotaxime or ceftriaxone as
    empiric treatment until culture and
    susceptibility results are available
  • Dexamethasone is 0.15 mg/kg every six hours
  • suspected pneumococcal meningitis and a Glasgow
    coma scale score of 8 to 11
  • should be continued for four days if the Gram
    stain reveals organisms consistent with S.
    pneumoniae
  • should be discontinued if the gram stain and/or
    cultures reveal another pathogen
  • If using steroids, use Rifampin in place of Vanc.

17
E. Coli Meningitis
  • Complications
  • Ventriculitis
  • Subdural effusion
  • Brain abscess
  • Syndrome of inappropriate antidiuretic hormone
    secretion
  • Hydrocephalus
  • Seizure disorder
  • Spastic paralysis
  • Mental retardation
  • Hearing deficit
  • Metastatic septic abscesses
  • Acute disseminated encephalomyelitis

18
E. Coli Meningitis
  • Prognosis
  • In virtually all studies, one of the most
    important factors predicting survival is the
    state of consciousness at the time of admission.
  • In a large series from Massachusetts, patients
    who were unresponsive or responsive only to pain
    had a 49 percent mortality rate compared to 16
    percent for those who were alert or only
    lethargic

19
Bartholin's Gland
  • The two Bartholin's glands secrete mucus to
    provide moisture for the vulva
  • Cysts and abscesses are the most common disorders

www.aafp.org
www.aafp.org
20
Bartholin's Gland
  • Bartholin's Gland Cyst
  • Chronic inflammation can obstruct the orifice of
    the Bartholin's gland duct
  • leads to cystic dilatation of the duct
  • Bartholin's Gland Abscess
  • Result of a polymicrobial infection
  • The predominant aerobic and facultative bacteria
    are Escherichia coli and N. gonorrhea
  • The most common anaerobic bacteria are
    Bacteroides species.

21
Conclusion
  • E. coli meningitis is a very rare disease with a
    very high mortality rate.
  • Most common causes in adults were from
    neurosurgical procedures, trauma or urinary tract
    manipulation
  • In a literature search from 1966 to the present,
    a case of E. coli meningitis resulting from
    incision and drainage of a bartholins gland has
    not been found.

22
  • Thank You
Write a Comment
User Comments (0)
About PowerShow.com